AVP and type 2 diabetes mellitus: A study that included 268 patients with severe HF in NYHA functional classes III-IV, 42% with T2DM, demonstrated that copeptin is a good predictor of rehospitalizations and mortality, with a superior value in comparison to BNP [57].